In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
Opening the digital front door to advanced healthcare
Pharmaceutical research in space
Precision medicine in mental health - one size really doesn’t fit all
Where are the pharma voices in US politics?
A clearer harmony and attractiveness for EU Clinical Trials Regulation
Making connections and getting noticed as a biotech start-up
Getting down to the nitty gritty of actively creating healthier societies
How manufacturing keeps pace with innovation in cell and gene therapy
Fixing the inequity of drug access outside of the US
Key themes from JP Morgan
Prediction is very difficult, especially if it’s about the future
Promoting value-added medicines and renovating old medicines smartly
Digitisation of drug R&D: Avoiding new for novelty’s sake
The problems of animal research for human medicine and the alternatives
The race to develop innovative products and supply chain solutions
The smart-design evolution of the laboratory space
Investing in the gleams of positivity and hope for life sciences innovation
Looking to the future of UK medical device exports
Exploring the reasons behind increasing burdens on clinical research sites
An investor’s perspective on bio and tech
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology